Vaidya Sane Ayurved Laboratories Ltd.
•₹ 169.952.41%
2026-08-21
ABOUT
KEY POINTS
Revenue Breakup Mar 2025 • Sale of Product Activity: 64.4% • Hospital Activity: 26.6% • Common / Unallocable: 8.9%
PROS
- Company is almost debt free
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 0.95x)
- Company comfortably covers its interest (33.2x coverage)
- Company generates healthy free cash flow
CONS
- Receivables are growing faster than sales - a possible quality concern
- Company has a low return on equity of 8.6% over last 3 years
- A large part of profit comes from other income (25.8% of PBT)
- Company has a low return on capital employed of 11.8%
- Company has delivered a poor sales growth of 3.0% over past five years
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | APOLLOHOSP | 8799.00 | 60.55 | 126516.12 | 0.23 | 610.40 | 38.41 | 7043.50 | 20.56 | 21.73 | 15.70 |
| 2. | MANIPALHOS | 744.55 | 109.75 | 97936.41 | 0.00 | — | — | — | — | 13.93 | — |
| 3. | MAXHEALTH | 996.45 | 66.57 | 96982.14 | 0.20 | 322.96 | 4.87 | 2366.17 | 16.70 | 14.97 | 25.29 |
| 4. | ASTERDM | 800.70 | 219.01 | 69794.81 | 0.00 | 29.28 | -68.70 | 1310.68 | 21.60 | 11.46 | 19.53 |
| 5. | FORTIS | 910.80 | 65.62 | 68761.59 | 0.11 | 272.80 | 2.26 | 2545.03 | 17.46 | 14.07 | 21.28 |
| 6. | MEDANTA | 1419.05 | 68.60 | 38154.25 | 0.04 | 157.25 | -1.09 | 1304.05 | 26.50 | 20.50 | 21.99 |
| 7. | NH | 1782.70 | 44.64 | 36431.40 | 0.25 | 207.27 | 5.37 | 2683.63 | 78.05 | 16.20 | 17.43 |
| 8. | KIMS | 788.60 | 162.12 | 33121.71 | 0.00 | 37.40 | -56.00 | 1179.50 | 35.33 | 11.51 | 19.03 |
| 9. | LALPATHLAB | 1886.80 | 58.44 | 31669.72 | 1.09 | 1705.00 | 1172.39 | 7977.00 | 1090.95 | 29.56 | 31.03 |
| 10. | AGARWALEYE | 499.70 | 106.77 | 15841.80 | 0.00 | 55.02 | 44.56 | 614.02 | 25.97 | 14.32 | 27.75 |
| 11. | VIJAYA | 1489.70 | 81.84 | 15343.57 | 0.13 | 53.10 | 37.61 | 230.98 | 22.83 | 30.27 | 42.66 |
| 12. | MADHAVBAUG | 165.50 | 19.36 | 174.00 | 0.00 | — | — | — | — | 16.70 | — |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
No standalone quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| 62 | 75 | 52 | 75 | 99 | 97 | 87 | |
| 59 | 72 | 49 | 67 | 90 | 94 | 77 | |
| Operating Profit | 3 | 3 | 3 | 8 | 10 | 5 | 12 |
| OPM % | 5 | 4 | 7 | 10 | 10 | 5 | 14 |
| Other Income | 0 | 0 | 0 | 0 | 1 | 2 | 2 |
| Interest | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
| Depreciation | 2 | 2 | 2 | 2 | 3 | 3 | 4 |
| 1 | -0 | 0 | 5 | 7 | 1 | 7 | |
| Tax % | 44 | -25 | 14 | 27 | 25 | 28 | 29 |
| Net Profit | 0 | -1 | 0 | 3 | 5 | 1 | 5 |
| EPS | 110 | -124 | 87 | 8 | 5 | 1 | 5 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 5 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 1 | -1 | 1 | 3 | 5 | 1 | 5 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 1 | -1 | 1 | 3 | 5 | 1 | 5 |
Mar 2019
- 62
- 59
- Operating Profit
- 3
- OPM %
- 5
- Other Income
- 0
- Interest
- 1
- Depreciation
- 2
- 1
- Tax %
- 44
- Net Profit
- 0
- EPS
- 110
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2020
- 75
- 72
- Operating Profit
- 3
- OPM %
- 4
- Other Income
- 0
- Interest
- 1
- Depreciation
- 2
- -0
- Tax %
- -25
- Net Profit
- -1
- EPS
- -124
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -1
Mar 2021
- 52
- 49
- Operating Profit
- 3
- OPM %
- 7
- Other Income
- 0
- Interest
- 1
- Depreciation
- 2
- 0
- Tax %
- 14
- Net Profit
- 0
- EPS
- 87
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2022
- 75
- 67
- Operating Profit
- 8
- OPM %
- 10
- Other Income
- 0
- Interest
- 1
- Depreciation
- 2
- 5
- Tax %
- 27
- Net Profit
- 3
- EPS
- 8
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
Mar 2023
- 99
- 90
- Operating Profit
- 10
- OPM %
- 10
- Other Income
- 1
- Interest
- 1
- Depreciation
- 3
- 7
- Tax %
- 25
- Net Profit
- 5
- EPS
- 5
- Dividend Payout %
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
Mar 2024
- 97
- 94
- Operating Profit
- 5
- OPM %
- 5
- Other Income
- 2
- Interest
- 0
- Depreciation
- 3
- 1
- Tax %
- 28
- Net Profit
- 1
- EPS
- 1
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2025
- 87
- 77
- Operating Profit
- 12
- OPM %
- 14
- Other Income
- 2
- Interest
- 0
- Depreciation
- 4
- 7
- Tax %
- 29
- Net Profit
- 5
- EPS
- 5
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- 3%
- 3 Years:
- 5%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 12%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- -15%
- 1 Year:
- 42%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 9%
- 3 Years:
- 9%
- Last Year:
- 10%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - |
| Equity Capital | 0 | 0 | 0 | 11 | 11 | 11 | 11 |
| 9 | 8 | 10 | 25 | 30 | 31 | 49 | |
| 9 | 6 | 1 | 1 | 0 | 2 | 1 | |
| Trade Payables | 6 | 8 | 7 | 7 | 9 | 9 | 7 |
| 5 | 7 | 8 | 6 | 5 | 19 | 5 | |
| Total Liabilities | 29 | 29 | 26 | 50 | 55 | 71 | 74 |
| ASSETS | - | - | - | - | - | - | - |
| 16 | 16 | 17 | 17 | 21 | 22 | 27 | |
| Capital Work in Progress | 2 | 4 | 0 | 1 | 2 | 1 | 0 |
| 0 | 0 | 0 | 21 | 15 | 25 | 26 | |
| 4 | 3 | 2 | 2 | 3 | 3 | 2 | |
| 0 | 0 | 0 | 0 | 0 | 6 | 7 | |
| Cash & Bank | 1 | 1 | 1 | 3 | 2 | 2 | 2 |
| 7 | 6 | 6 | 6 | 13 | 11 | 9 | |
| Total Assets | 29 | 29 | 26 | 50 | 55 | 71 | 74 |
| Total Debt | 9 | 6 | 1 | 1 | 0 | 2 | 1 |
| Net Working Capital | -9 | -10 | -7 | 13 | 16 | 17 | 14 |
| Contingent Liabilities | 0 | 0 | 1 | 1 | 1 | 1 | 3 |
| Book Value per Share | 1951.11 | 1826.64 | 2170.44 | 34.13 | 38.82 | 39.56 | 56.78 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Total Debt | 9 | 6 | 1 | 1 | 0 | 2 | 1 |
| Net Working Capital | -9 | -10 | -7 | 13 | 16 | 17 | 14 |
| Contingent Liabilities | 0 | 0 | 1 | 1 | 1 | 1 | 3 |
| Book Value per Share | 1951.11 | 1826.64 | 2170.44 | 34.13 | 38.82 | 39.56 | 56.78 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Mar 2019
- Equity Capital
- 0
- 9
- 9
- Trade Payables
- 6
- 5
- Total Liabilities
- 29
- 16
- Capital Work in Progress
- 2
- 0
- 4
- 0
- Cash & Bank
- 1
- 7
- Total Assets
- 29
- Total Debt
- 9
- Net Working Capital
- -9
- Contingent Liabilities
- 0
- Book Value per Share
- 1951.11
- Face Value
- 10.00
- Total Debt
- 9
- Net Working Capital
- -9
- Contingent Liabilities
- 0
- Book Value per Share
- 1951.11
- Face Value
- 10.00
Mar 2020
- Equity Capital
- 0
- 8
- 6
- Trade Payables
- 8
- 7
- Total Liabilities
- 29
- 16
- Capital Work in Progress
- 4
- 0
- 3
- 0
- Cash & Bank
- 1
- 6
- Total Assets
- 29
- Total Debt
- 6
- Net Working Capital
- -10
- Contingent Liabilities
- 0
- Book Value per Share
- 1826.64
- Face Value
- 10.00
- Total Debt
- 6
- Net Working Capital
- -10
- Contingent Liabilities
- 0
- Book Value per Share
- 1826.64
- Face Value
- 10.00
Mar 2021
- Equity Capital
- 0
- 10
- 1
- Trade Payables
- 7
- 8
- Total Liabilities
- 26
- 17
- Capital Work in Progress
- 0
- 0
- 2
- 0
- Cash & Bank
- 1
- 6
- Total Assets
- 26
- Total Debt
- 1
- Net Working Capital
- -7
- Contingent Liabilities
- 1
- Book Value per Share
- 2170.44
- Face Value
- 10.00
- Total Debt
- 1
- Net Working Capital
- -7
- Contingent Liabilities
- 1
- Book Value per Share
- 2170.44
- Face Value
- 10.00
Mar 2022
- Equity Capital
- 11
- 25
- 1
- Trade Payables
- 7
- 6
- Total Liabilities
- 50
- 17
- Capital Work in Progress
- 1
- 21
- 2
- 0
- Cash & Bank
- 3
- 6
- Total Assets
- 50
- Total Debt
- 1
- Net Working Capital
- 13
- Contingent Liabilities
- 1
- Book Value per Share
- 34.13
- Face Value
- 10.00
- Total Debt
- 1
- Net Working Capital
- 13
- Contingent Liabilities
- 1
- Book Value per Share
- 34.13
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 11
- 30
- 0
- Trade Payables
- 9
- 5
- Total Liabilities
- 55
- 21
- Capital Work in Progress
- 2
- 15
- 3
- 0
- Cash & Bank
- 2
- 13
- Total Assets
- 55
- Total Debt
- 0
- Net Working Capital
- 16
- Contingent Liabilities
- 1
- Book Value per Share
- 38.82
- Face Value
- 10.00
- Total Debt
- 0
- Net Working Capital
- 16
- Contingent Liabilities
- 1
- Book Value per Share
- 38.82
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 11
- 31
- 2
- Trade Payables
- 9
- 19
- Total Liabilities
- 71
- 22
- Capital Work in Progress
- 1
- 25
- 3
- 6
- Cash & Bank
- 2
- 11
- Total Assets
- 71
- Total Debt
- 2
- Net Working Capital
- 17
- Contingent Liabilities
- 1
- Book Value per Share
- 39.56
- Face Value
- 10.00
- Total Debt
- 2
- Net Working Capital
- 17
- Contingent Liabilities
- 1
- Book Value per Share
- 39.56
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 11
- 49
- 1
- Trade Payables
- 7
- 5
- Total Liabilities
- 74
- 27
- Capital Work in Progress
- 0
- 26
- 2
- 7
- Cash & Bank
- 2
- 9
- Total Assets
- 74
- Total Debt
- 1
- Net Working Capital
- 14
- Contingent Liabilities
- 3
- Book Value per Share
- 56.78
- Face Value
- 10.00
- Total Debt
- 1
- Net Working Capital
- 14
- Contingent Liabilities
- 3
- Book Value per Share
- 56.78
- Face Value
- 10.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| 2 | 8 | 6 | -13 | -0 | 3 | 8 | |
| Cash from Investing | -10 | -4 | -1 | -8 | 1 | -17 | -7 |
| Cash from Financing | 8 | -4 | -5 | 22 | -1 | 14 | -1 |
| -1 | 0 | -0 | 2 | -1 | 0 | 0 | |
| Free Cash Flow | 2 | 4 | 5 | -16 | -7 | -0 | 0 |
| OCF / Net Profit | 3.19 | -13.86 | 14.71 | -3.84 | -0.08 | 3.24 | 1.55 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | -15 | -19 |
| OCF / Net Profit | 3.19 | -13.86 | 14.71 | -3.84 | -0.08 | 3.24 | 1.55 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | -15 | -19 |
Mar 2019
- 2
- Cash from Investing
- -10
- Cash from Financing
- 8
- -1
- Free Cash Flow
- 2
- OCF / Net Profit
- 3.19
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 3.19
- Cumulative 5-Year FCF
- 0
Mar 2020
- 8
- Cash from Investing
- -4
- Cash from Financing
- -4
- 0
- Free Cash Flow
- 4
- OCF / Net Profit
- -13.86
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -13.86
- Cumulative 5-Year FCF
- 0
Mar 2021
- 6
- Cash from Investing
- -1
- Cash from Financing
- -5
- -0
- Free Cash Flow
- 5
- OCF / Net Profit
- 14.71
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 14.71
- Cumulative 5-Year FCF
- 0
Mar 2022
- -13
- Cash from Investing
- -8
- Cash from Financing
- 22
- 2
- Free Cash Flow
- -16
- OCF / Net Profit
- -3.84
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -3.84
- Cumulative 5-Year FCF
- 0
Mar 2023
- -0
- Cash from Investing
- 1
- Cash from Financing
- -1
- -1
- Free Cash Flow
- -7
- OCF / Net Profit
- -0.08
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.08
- Cumulative 5-Year FCF
- 0
Mar 2024
- 3
- Cash from Investing
- -17
- Cash from Financing
- 14
- 0
- Free Cash Flow
- -0
- OCF / Net Profit
- 3.24
- Cumulative 5-Year FCF
- -15
- OCF / Net Profit
- 3.24
- Cumulative 5-Year FCF
- -15
Mar 2025
- 8
- Cash from Investing
- -7
- Cash from Financing
- -1
- 0
- Free Cash Flow
- 0
- OCF / Net Profit
- 1.55
- Cumulative 5-Year FCF
- -19
- OCF / Net Profit
- 1.55
- Cumulative 5-Year FCF
- -19
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - |
| EPS (₹) | 110.20 | -123.82 | 87.11 | 3.30 | 4.94 | 0.99 | 4.66 |
| Book Value (₹) | 1951.11 | 1826.64 | 2170.44 | 34.13 | 38.82 | 39.56 | 56.78 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.25 | 0.00 | 0.00 |
| Cash EPS (₹) | 2.99 | 2.39 | 4.07 | 5.47 | 7.41 | 3.87 | 8.20 |
| PROFITABILITY | - | - | - | - | - | - | - |
| Operating Margin % | 5.07% | 3.95% | 6.52% | 10.26% | 10.47% | 3.26% | 11.76% |
| Net Margin % | 0.79% | -0.74% | 0.75% | 4.64% | 5.24% | 1.07% | 5.62% |
| ROE % | 5.65% | -6.56% | 4.36% | 15.20% | 13.53% | 2.54% | 9.67% |
| ROCE % | 9.04% | 4.73% | 7.69% | 22.53% | 19.94% | 3.50% | 12.02% |
| 1.72% | -1.92% | 1.43% | 9.16% | 9.86% | 1.66% | 6.77% | |
| EFFICIENCY | - | - | - | - | - | - | - |
| Debtor Days | 21 | 15 | 18 | 15 | 18 | 23 | 27 |
| Inventory Days | 21 | 16 | 16 | 8 | 9 | 12 | 11 |
| Payable Days | 138 | 124 | 162 | 117 | 108 | 115 | 122 |
| -95 | -94 | -128 | -94 | -80 | -80 | -85 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.99x | 0.73x | 0.10x | 0.03x | 0.00x | 0.04x | 0.02x |
| Interest Coverage (x) | 2.27x | 0.63x | 1.90x | 8.57x | 9.08x | 6.70x | 33.24x |
| 0.53x | 0.45x | 0.52x | 2.04x | 2.24x | 2.27x | 2.29x | |
| GROWTH | - | - | - | - | - | - | - |
| Revenue Growth % | 0.00% | 20.38% | -30.51% | 42.92% | 32.55% | -1.71% | -10.50% |
| Operating Profit Growth % | 0.00% | -6.15% | 14.55% | 124.86% | 35.25% | -54.32% | 153.75% |
| Net Profit Growth % | 0.00% | -212.36% | 170.35% | 784.95% | 49.61% | -79.87% | 368.58% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -79.86% | 368.56% | |
| VALUATION | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 175.05x | 20.12x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 4.40x | 1.65x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 38.54x | 8.13x |
Mar 2019
- EPS (₹)
- 110.20
- Book Value (₹)
- 1951.11
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 2.99
- Operating Margin %
- 5.07%
- Net Margin %
- 0.79%
- ROE %
- 5.65%
- ROCE %
- 9.04%
- 1.72%
- Debtor Days
- 21
- Inventory Days
- 21
- Payable Days
- 138
- -95
- Debt to Equity (x)
- 0.99x
- Interest Coverage (x)
- 2.27x
- 0.53x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- -123.82
- Book Value (₹)
- 1826.64
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 2.39
- Operating Margin %
- 3.95%
- Net Margin %
- -0.74%
- ROE %
- -6.56%
- ROCE %
- 4.73%
- -1.92%
- Debtor Days
- 15
- Inventory Days
- 16
- Payable Days
- 124
- -94
- Debt to Equity (x)
- 0.73x
- Interest Coverage (x)
- 0.63x
- 0.45x
- Revenue Growth %
- 20.38%
- Operating Profit Growth %
- -6.15%
- Net Profit Growth %
- -212.36%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 87.11
- Book Value (₹)
- 2170.44
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 4.07
- Operating Margin %
- 6.52%
- Net Margin %
- 0.75%
- ROE %
- 4.36%
- ROCE %
- 7.69%
- 1.43%
- Debtor Days
- 18
- Inventory Days
- 16
- Payable Days
- 162
- -128
- Debt to Equity (x)
- 0.10x
- Interest Coverage (x)
- 1.90x
- 0.52x
- Revenue Growth %
- -30.51%
- Operating Profit Growth %
- 14.55%
- Net Profit Growth %
- 170.35%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 3.30
- Book Value (₹)
- 34.13
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 5.47
- Operating Margin %
- 10.26%
- Net Margin %
- 4.64%
- ROE %
- 15.20%
- ROCE %
- 22.53%
- 9.16%
- Debtor Days
- 15
- Inventory Days
- 8
- Payable Days
- 117
- -94
- Debt to Equity (x)
- 0.03x
- Interest Coverage (x)
- 8.57x
- 2.04x
- Revenue Growth %
- 42.92%
- Operating Profit Growth %
- 124.86%
- Net Profit Growth %
- 784.95%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 4.94
- Book Value (₹)
- 38.82
- Dividend per Share (₹)
- 0.25
- Cash EPS (₹)
- 7.41
- Operating Margin %
- 10.47%
- Net Margin %
- 5.24%
- ROE %
- 13.53%
- ROCE %
- 19.94%
- 9.86%
- Debtor Days
- 18
- Inventory Days
- 9
- Payable Days
- 108
- -80
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 9.08x
- 2.24x
- Revenue Growth %
- 32.55%
- Operating Profit Growth %
- 35.25%
- Net Profit Growth %
- 49.61%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 0.99
- Book Value (₹)
- 39.56
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 3.87
- Operating Margin %
- 3.26%
- Net Margin %
- 1.07%
- ROE %
- 2.54%
- ROCE %
- 3.50%
- 1.66%
- Debtor Days
- 23
- Inventory Days
- 12
- Payable Days
- 115
- -80
- Debt to Equity (x)
- 0.04x
- Interest Coverage (x)
- 6.70x
- 2.27x
- Revenue Growth %
- -1.71%
- Operating Profit Growth %
- -54.32%
- Net Profit Growth %
- -79.87%
- -79.86%
- P/E (x)
- 175.05x
- P/B (x)
- 4.40x
- Dividend Yield %
- 0.00%
- 38.54x
Mar 2025
- EPS (₹)
- 4.66
- Book Value (₹)
- 56.78
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 8.20
- Operating Margin %
- 11.76%
- Net Margin %
- 5.62%
- ROE %
- 9.67%
- ROCE %
- 12.02%
- 6.77%
- Debtor Days
- 27
- Inventory Days
- 11
- Payable Days
- 122
- -85
- Debt to Equity (x)
- 0.02x
- Interest Coverage (x)
- 33.24x
- 2.29x
- Revenue Growth %
- -10.50%
- Operating Profit Growth %
- 153.75%
- Net Profit Growth %
- 368.58%
- 368.56%
- P/E (x)
- 20.12x
- P/B (x)
- 1.65x
- Dividend Yield %
- 0.00%
- 8.13x
Documents
Announcements
Nothing filed yet.
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
May 2026
Nov 2025
May 2025